Salvage Strategies for Management of Testicular Tumors

被引:0
|
作者
Chatterjee S. [1 ]
Rawal S.K. [1 ]
机构
[1] Department of Surgical Oncology and Uro-oncology, Rajeev Gandhi Cancer Institute and Research Centre, Rohini Sector 5, New Delhi
关键词
Cisplatin; Testicular cancer; Testicular tumors;
D O I
10.1007/s13193-016-0614-1
中图分类号
学科分类号
摘要
Testicular germ cell tumors (GCTs) comprise 2% of all human male malignancies and are the most common solid tumors in men between ages 15 and 35 years. Risk of contralateral testicular GCT is between 1 and 5%. Partial orchidectomy (PO) was originally described in 1984 by Richie. The evolving indications include metachronous tumors and tumor in solitary testicles. Also, small non-palpable lesions detected only by ultrasonography (USG) in asymptomatic patients is another indication. Salvagability is only chosen for tumors less than 2 cm in size. The key feature of PO is an inguinal approach with early vascular control using a rubber tourniquet before testicular mobilization into the field to avoid systemic tumor seeding. After, mass excision with a margin mandatory frozen section is done to assess adequacy of resection. Intra-op USG may be beneficial in small non-palpable lesions. Post op tumor markers are assessed and patients are taught self-examination of testis. Recent series shows that PO is safe and gives adequate oncological control. Carcinoma in situ (CIS) in the affected testis at PO or after testicular sparing surgery remains a challenge. At most centers, 20 Gy is recommended when adjuvant local radiation treatment is chosen to treat CIS. But this dose may hamper Androgen production. Radical orchiectomy remains the gold standard and should be discussed as part of informed consent. It is mandatory to highlight the risks of local recurrence and CIS, and treatment (observation, radiation, or completion orchiectomy) as well as the need for androgen supplementation and fertility risks before choosing testicular salvage procedures. © 2016, Indian Association of Surgical Oncology.
引用
收藏
页码:389 / 396
页数:7
相关论文
共 50 条
  • [31] Management of recurrent testicular germ cell tumors
    Sonpavde, Guru
    Hutson, Thomas E.
    Roth, Bruce J.
    ONCOLOGIST, 2007, 12 (01): : 51 - 61
  • [32] MANAGEMENT OF PRIMARY TESTICULAR-TUMORS IN CHILDREN
    MARTINEZMORA, J
    SANCHOCERQUELLA, V
    PADULLES, J
    PRATS, J
    BOIXOCHOA, J
    MORAGAS, A
    PLANS, B
    JOURNAL OF PEDIATRIC SURGERY, 1980, 15 (03) : 283 - 286
  • [33] Testicular Sarcoidosis: Diagnostic Approach and Management Strategies
    Ballet, Brice
    Roelandt, Marc
    Lockefeer, Fabrice
    Thuer, David
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (01)
  • [34] RENOGRAPHY AS AN AID TO THE MANAGEMENT OF METASTATIC TESTICULAR-TUMORS
    BENGHIAT, A
    COHEN, MEL
    COLLIS, SA
    BRITISH JOURNAL OF RADIOLOGY, 1988, 61 (728): : 742 - 742
  • [35] Management of residual masses in testicular germ cell tumors
    Heidenreich, Axel
    Paffenholz, Pia
    Nestler, Tim
    Pfister, David
    EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (04) : 291 - 300
  • [36] Testicular Tumors High Likelihood of Cure With Interdisciplinary Management
    Krege, Susanne
    Oing, Christoph
    Bokemeyer, Carsten
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2023, 120 (49): : 843 - 854
  • [38] MANAGEMENT OF NON-SEMINOMATOUS TESTICULAR-TUMORS
    LEVI, JA
    MEDICAL JOURNAL OF AUSTRALIA, 1979, 1 (09) : 395 - 396
  • [39] PROGRESS IN THE MANAGEMENT OF TESTICULAR GERM-CELL TUMORS
    OLIVER, RTD
    PRACTITIONER, 1982, 226 (1373) : 1903 - &
  • [40] State-of-the-art surgical management of testicular tumors
    Shah, Ketul
    Pohar, Kamal
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (09) : 1301 - 1308